You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. TERNS PHARMACEUTICALS INC

Terns Pharmaceuticals Inc XNAS: TERN

Terns Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Download real time

3.35 0.21 (6.69%)

New 52W Low in past week

1.8M XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
12.2 / 100
Momentum Score
Technically Bearish
25.5 / 100
Analyst Price Target
No estimates available

9

S

15

W

3

O

1

T

SWOT Analysis

Check P/E Buy Sell Zone

This stock has negative PE


Terns Pharmaceuticals Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Terns Pharmaceuticals Inc Stock Analysis

Terns Pharmaceuticals Inc stock analysis with key metrics, changes, and trends.

Terns Pharmaceuticals Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Net Profit$88.85 M1.5%positive

Annual Net Profit rose 1.5% in the last year to $88.85 M. Its sector's average net profit growth for the last fiscal year was -32.43%.

Price to Earning Ratio-3.44-negative

Price to Earning Ratio is -3.44, which is negative.

Stock Price$3.35-48.85%negative

Stock Price fell 48.85% and underperformed its sector by 57.92% in the past year.

Quarterly Net profit$21.8 M3.71%negative

Quarterly Net profit fell 3.71% YoY to $21.8 M. Its sector's average net profit growth YoY for the quarter was -47.3%.

Mutual Fund Holding30.95 %4.52%positive

Mutual Fund Holding increased by 4.52% in the last quarter to 30.95.

Institutional Holding99.80 %6.11%positive

Institutional Holding increased by 6.11% in the last quarter to 99.8.

VIEW LESS


Loading data..

Terns Pharmaceuticals Inc - Company Profile

What does Terns Pharmaceuticals Inc do?

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.

Terns Pharmaceuticals Inc Management structure

All Gross Remunerations are in USD
Dr. Mark J. Vignola, PhD
Principal Accounting Officer, Chief Financial Officer and Treasurer
-
2025
Gross Remuneration
Year
Mr. David Eric Strauss
Corporate Controller and Vice President, Finance
-
2025
Gross Remuneration
Year
Ms. Amy Burroughs
Chief Executive Officer and Director
-
2025
Gross Remuneration
Year
Mr. Andrew Gengos
Chief Financial Officer
-
2025
Gross Remuneration
Year

Terns Pharmaceuticals Inc Board of directors

All Gross Remunerations are in USD
Ms. Amy Burroughs
Chief Executive Officer and Director
-
2025
Gross Remuneration
Year
Dr. Carl L. Gordon, C.F.A.,PhD
Independent Director
-
2025
Gross Remuneration
Year
Mr. Robert W. Azelby
Director
-
2025
Gross Remuneration
Year

Terns Pharmaceuticals Inc FAQ

How is Terns Pharmaceuticals Inc today?
Terns Pharmaceuticals Inc today is trading in the green, and is up by 6.69% at 3.35.
Terns Pharmaceuticals Inc is currently trading up 6.69% on an intraday basis. In the past week the stock rose 5.35%. stock has been down -42.83% in the past quarter and fell -48.85% in the past year. You can view this in the overview section.